Sinem Civriz Bozdağ
Sinem Civriz Bozdağ publishes mostly in Hematology, Genetics and Oncology, on topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #7,643,000 of 7,710,434 ranked researchers
- Rank in Türkiye
- #115,124 of 117,622
- Works
- 189
- Citations
- 637
- Citations per work
- 3.4
What does Sinem Civriz Bozdağ research?
Sinem Civriz Bozdağ's work is mostly in Medicine (59%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11259.0%
- Medicine11259.0%
- Everything else6634.9%
- Life Sciences126.1%
- 1Hematology28% of their works
- 2Genetics12% of their works
- 3Oncology9% of their works
- 4Pathology and Forensic Medicine6% of their works
- 5Immunology6% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
Which keywords describe Sinem Civriz Bozdağ's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Bone Marrow Niche, Graft-versus-Host Disease, Rituximab, Acute Myeloid Leukemia, AML and Minimal Residual Disease.
- Childhood Cancer
- Myelofibrosis
- International Myeloma Working Group
- Imatinib
- Chronic Lymphocytic Leukemia
- Lymphoma
- Minimal Residual Disease
- AML
- Graft-versus-Host Disease
- Prognostic Factors
- Hematopoietic Stem Cells
- Bone Marrow Niche
- Rituximab
- Acute Myeloid Leukemia
- Classification
- BCR-ABL
- Genomic Aberrations
- Diagnosis Criteria
- JAK2 Mutation
- Acute Lymphoblastic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Hematopoietic Stem Cells902 topics
- Prognostic Factors703 topics
- Bone Marrow Niche581 topic
- Graft-versus-Host Disease581 topic
- Rituximab522 topics
- AML321 topic
- Acute Myeloid Leukemia321 topic
- Minimal Residual Disease292 topics
- Classification271 topic
- Lymphoma271 topic
- BCR-ABL251 topic
- Chronic Lymphocytic Leukemia251 topic
- Genomic Aberrations251 topic
- Imatinib251 topic
- Diagnosis Criteria161 topic
- International Myeloma Working Group161 topic
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- Acute Lymphoblastic Leukemia131 topic
- Childhood Cancer131 topic
Where does Sinem Civriz Bozdağ work?
Sinem Civriz Bozdağ's main affiliation in the publication record is Ankara University, Türkiye.
How many publications and citations does Sinem Civriz Bozdağ have?
OpenAlex counts 189 works and 637 citations for Sinem Civriz Bozdağ, an h-index of 12, ranking #7,643,000 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sinem Civriz Bozdağ. Posts are plain text and can be reported.